In an 80-year-old man with markedly elevated prostate-specific antigen (PSA), low PSA density, a PI‑RADS 2 prostate MRI, and a PET scan showing no suspicious pelvic lesions, who recently underwent sigmoid colon cancer resection, what is the recommended next step in evaluating his prostate?

Prostate Biopsy is NOT Recommended in This 80-Year-Old Man

Given the combination of PI-RADS 2 (low suspicion), very low PSA density of 0.07 ng/ml/ml, negative PET scan, and age 80 years, the elevated PSA of 18.62 is most likely explained by benign prostatic hyperplasia rather than clinically significant prostate cancer, and biopsy should be avoided.

Clinical Reasoning

Why Biopsy is Not Indicated

The patient presents with discordant findings that strongly argue against clinically significant prostate cancer:

• PI-RADS 2 lesion: This indicates benign tissue or clinically insignificant disease. Recent evidence shows that for PI-RADS ≤2 lesions, the optimal PSA density threshold for considering biopsy is 0.20 ng/ml/ml 12. Your patient's PSA density of 0.07 is far below this threshold.

• Extremely low PSA density: At 0.07 ng/ml/ml, this is less than half the traditional 0.15 ng/ml/ml cutoff and well below even the most conservative thresholds. Multiple recent studies confirm that PSA density <0.10 ng/ml/ml in patients with negative MRI yields only a 4% probability of clinically significant prostate cancer 2. The post-test probability drops even further with PI-RADS 2 findings.

• Negative PET scan: The absence of hypermetabolic pelvic lesions provides additional reassurance against aggressive disease.

The Age Factor

At 80 years old, this patient falls into a category where screening and aggressive workup are generally not recommended 344. The 2013 AUA Best Practice Statement explicitly notes that men over 75 should not routinely undergo PSA testing unless they have excellent health and family longevity 44. Even if prostate cancer were present, the likelihood of it affecting his mortality or quality of life during his remaining lifespan is low, particularly given his recent major surgery for colon cancer.

Alternative Explanation for Elevated PSA

The markedly elevated PSA (18.62) with very low PSA density (0.07) indicates a large prostate volume (approximately 266 ml by calculation). This pattern is classic for benign prostatic hyperplasia (BPH), not cancer. Recent evidence demonstrates that PSA density performance deteriorates significantly in men with large prostates (>60 ml), and in prostates >80 ml, diagnostic accuracy drops substantially 15.

Recommended Management Approach

Immediate Actions

1. Workup for benign disease: Evaluate for BPH, prostatitis, or urinary retention that could explain the PSA elevation 6

   • Assess urinary symptoms using validated questionnaires (IPSS)
   • Check post-void residual volume
   • Consider urinalysis and urine culture to exclude infection

2. Repeat PSA in 6-12 months with digital rectal examination 6

   • Ensure no recent ejaculation, vigorous exercise, or urinary instrumentation for 48 hours before testing 3
   • Calculate PSA velocity over time

Surveillance Strategy

• Serial PSA monitoring every 6-12 months 76
• Repeat MRI only if PSA shows rapid rise (>2.0 ng/ml/year) or new urinary symptoms develop 44
• Consider biopsy only if:
  • PSA density rises above 0.15 ng/ml/ml on repeat imaging 82
  • MRI shows progression to PI-RADS ≥3 9
  • Development of concerning clinical symptoms

Critical Pitfalls to Avoid

Do not reflexively biopsy based on PSA value alone in an elderly patient with reassuring imaging. The absolute PSA number of 18.62, while elevated, must be interpreted in context of:

• Prostate volume (PSA density is the key metric)
• MRI findings (PI-RADS 2 is reassuring)
• Patient age and life expectancy
• Competing mortality from recent colon cancer

Recognize that prostate biopsy carries real risks in an 80-year-old, including infection (potentially serious given recent abdominal surgery), bleeding, urinary retention, and the psychological burden of cancer diagnosis that may never require treatment 37.

The Recent Colon Cancer Context

The patient's recent sigmoid colon cancer resection is relevant for two reasons:

1. Competing mortality: His life expectancy may already be impacted by the colon cancer, further reducing any potential benefit from prostate cancer detection 44

2. False reassurance from PET: While the negative PET scan is helpful, standard FDG-PET has limited sensitivity for prostate cancer. However, the absence of suspicious lesions still provides some reassurance against aggressive disease.

The combination of advanced age, recent major cancer diagnosis, low PSA density, and benign MRI findings creates a clinical scenario where watchful waiting with PSA surveillance is far more appropriate than invasive biopsy.